Episode
There are no longevity drugs today, but there will be soon - Dr. James Peyer, Cambrian Founder
- Podcast
- Free Radicals
- Published
- Apr 28, 2026
- Duration seconds
- 4903
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/free-radicals-7588534/episodes/there-are-no-longevity-drugs-today-but-there-will-be-soon-dr-james-peyer-cambrian-founder/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/free-radicals-7588534/there-are-no-longevity-drugs-today-but-there-will-be-soon-dr-james-peyer-cambrian-founder.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr. James Peyer is founder and CEO of Cambrian Bio. James has spent two decades working to bring the first longevity drug to market. In this time, he’s brought over $500M into the field as a whole, and now has multiple drugs in clinical trials that could plausibly prove to be… the first true longevity drugs, or gerotherapeutics. In today’s episode, we dive into the history of the geroscience field. We discuss what makes geroscience’s approach to drug development so unique, how to unlock the flywheel of innovation that will get us longevity escape velocity, and Amplifier Therapeutics' “zone 2 in a pill”... which might prove to be the first ever true, longevity drug.